The Prognostic Value of Cardiac Biomarkers and Echocardiography in Critical COVID-19
Background: Early risk stratification is crucial in critically ill COVID-19 patients. Myocardial injury is associated with worse outcome. This study aimed to evaluate cardiac biomarkers and echocardiographic findings in critically ill COVID-19 patients and to assess their association with 30-day mor...
Guardado en:
Autores principales: | Bert Zwaenepoel, Sebastiaan Dhont, Eric Hoste, Sofie Gevaert, Hannah Schaubroeck |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/042c293720554194a9fe776a38e3ed9c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Normalized Cardiac Structure and Function in COVID-19 Survivors Late After Recovery
por: Yi-Ping Gao, et al.
Publicado: (2021) -
The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population
por: Zhu Q, et al.
Publicado: (2016) -
Comparison of prognostic values of high-sensitivity cardiac troponin T and N-terminal prohormone brain natriuretic peptide to assess mortality in elderly inpatients
por: Chen JR, et al.
Publicado: (2018) -
The predictive capacity and additional prognostic power of N-terminal pro-B-type natriuretic peptide in Chinese elderly with chronic heart failure
por: Fu S, et al.
Publicado: (2015) -
Heart Failure Probability and Early Outcomes of Critically Ill Patients With COVID-19: A Prospective, Multicenter Study
por: Weibo Gao, et al.
Publicado: (2021)